Watch the NEJM Quick Take video on this trial comparing fish oil and placebo in patients on hemodialysis.
More than two thirds of patients receiving hemodialysis for end-stage kidney disease are affected by cardiovascular disease. New research findings on fish-oil supplementation in patients treated with hemodialysis are summarized in a short video.
Citation(s):
Lok CE, et al. Fish-oil supplementation and cardiovascular events in patients receiving hemodialysis. N Engl J Med 2025 Nov 7; [e-pub]. DOI: 10.1056/NEJMoa2513032.